<DOC>
	<DOC>NCT01874691</DOC>
	<brief_summary>This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.</brief_summary>
	<brief_title>China Acute Myocardial Infarction Registry</brief_title>
	<detailed_description>The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI.</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute STelevation or non STelevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI. Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>acute myocardial infarction</keyword>
	<keyword>China</keyword>
	<keyword>Registry</keyword>
</DOC>